Medtech

A US generic approval for the single-dose flu drug baloxavir marboxil raises questions about access, pricing, and NHS formulary strategy.

The Emergency Use Listing marks a first for BDBV diagnostics, with implications for global outbreak preparedness and UK biosecurity planning.

The EMA's human medicines committee recommended six new treatments and two biosimilars at its latest monthly meeting.